DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $-0.09 · Revenue $77.25M · 2 analysts
Est. EPS $-0.07 · Revenue $80.28M · 2 analysts
Est. EPS $-0.51 · Revenue $306.50M · 2 analysts
Est. EPS $-0.09 · Revenue $79.86M · 1 analysts
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $322.2M | -47.7% | -2.8% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-182.4M | -1012.4% | -7.2% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +30.7% | -11.5% | -3.5% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -27.7% | -694.7% | +1.4% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -56.6% | -1845.9% | -10.3% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $27.0M | -58.1% | -87.9% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +8.4% | -19.8% | -93.4% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 20.3% | +13.7% | +1.0% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 2.26x | -9.7% | -7.4% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $217.1M | -52.4% | -10.7% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -1.84 vs -0.67 | -174.6% | -0.16 vs -0.09 | -71.8% |
| Revenue Surprise | $322.2M vs $317.5M | +1.5% | $73.4M vs $77.2M | -4.9% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| May 12, 2026 | Bienstock Lee | director, officer: Chief Executive Officer | Common Stock | D | 15,644 | $0.59 |
| Mar 30, 2026 | Bienstock Lee | director, officer: Chief Executive Officer | Common Stock | D | 18,811 | $0.57 |
| Dec 15, 2025 | Bienstock Lee | director, officer: Chief Executive Officer | Common Stock | D | 214,131 | $0.91 |
| Dec 15, 2025 | ROSENBERG NORMAN | officer: CFO and Treasurer | Common Stock | D | 65,774 | $0.91 |
| Dec 15, 2025 | Sugrue Stephen | officer: Chief Compliance Officer | Common Stock | D | 35,968 | $0.91 |
Operator: Good afternoon, ladies and gentlemen, and welcome to DocGo's second quarter earnings call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Monday, August 17th, 2026. I would now like to turn the conference over to Mike Cole, Vice President of Investor Relations. Please go ahead. Mike Cole: Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements made in this conference call, other than statements of historical fact, are forward-looking statements. The words may, will, plan, potential, could, goal, outlook, design, anticipate, aim, believe, estimate, expect, intend, guidance, confidence, target, project, and other similar expressions may be used to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance, and we cannot assure you that we will achieve or realize our plans, intentions, outcomes, results, or expectations. Forward-looking statements are inherently subject to substantial risks, uncertainties, and assumptions, many of which are beyond our control and which may cause our actual results or outcomes or the timing of results or outcomes to differ materially from those contained in our forward-looking statements. These risks, uncertainties, and assumptions include, but are not limited to those discussed in risk factors and elsewhere in DocGo's annual report on Form 10-K, quarterly reports on Form 10-Q, our earnings release for this quarter, and other reports and statements filed by DocGo with the SEC to which your attention is directed. Actual outcomes and results, or the timing of results or outcomes, may differ materially from what is expressed or implied by these forward-looking statements. In addition, today's call contains references to non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in our earnings release and the current report on Form 8-K that includes our earnings release, which is posted on our website, docgo.com, as well as filed with the SEC. The information contained in this call is accurate as of only the date discussed. Investors should not assume that statements will remain relevant and operative at a later time. We undertake no obligation to update any information discussed in this call to reflect events or circumstances after the date of this call or to reflect new information or the occurrence of unanticipated events, except as to the extent required by law. At this time, it is now my pleasure to turn the call over to Mr. Lee Bienstock, CEO of DocGo. Lee, please go ahead. Lee Bienstock: Thank you, Mike, and thank you all for joining us …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Lee Bienstock | Chief Executive Officer & Director | USD 1,645,605 | Male | 1985 | Active |
Ely D. Tendler | General Counsel, Secretary & Director | USD 1,225,422 | Male | 1968 | Active |
Norman Rosenberg | Treasurer & Chief Financial Officer | USD 953,743 | Male | 1970 | Active |
Stephen Sugrue | Chief Compliance Officer | USD 623,251 | Male | 1973 | Active |
Rosemarie Milano | Vice President of Human Resources | — | Female | — | Active |
James Powell | Chief Executive Officer of Clinical Practice Group & Member of Medical Advisory Board | — | — | — | Active |
Eiwe Lingefors | Chief Information Officer | — | Male | — | Active |
Mike Cole | Vice President of Investor Relations | — | Male | — | Active |
DocGo Inc. (Nasdaq: DCGO) (âDocGoâ), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bi
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Executive Officer, will participate in 1x1 meetings at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday September 16th, and will deliver a fireside presentation at 12:20 PM ET on that day. A webcast of the event will be available on the investor relations section of DocGo's we.
DocGo NASDAQ: DCGO reported second-quarter revenue of $73.4 million, down from $80.4 million a year earlier, as the company continued to wind down migrant-related projects. Excluding migrant-related revenue, revenue rose 19% year over year, while revenue from business lines operating in both periods increased about 5% after also excluding contributions from the SteadyMD acquisition.
DocGo Inc. (DCGO) Q2 2026 Earnings Call Transcript
DocGo Inc. (DCGO) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to a loss of $0.11 per share a year ago.
